The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis
- Conditions
- Severe Sepsis
- Registration Number
- NCT03141112
- Lead Sponsor
- Radovan Uvizl
- Brief Summary
The study will evaluate the benefit of early initiation of CRRT in the initial phase of severe sepsis in patients admitted to the ICU. Primary evaluated end-point is 28-day mortality. Secondarily evaluated end-point is length of ICU-stay, length of stay in hospital, duration of mechanical ventilation. There are two groups. One group of participants with early CRRT initiation and another group with late CRRT initiation. Reference group no CRRT.
- Detailed Description
The aim is to determine the optimal timing of initiation of CRRT with respect to the degree and duration of acute kidney injury (AKI) in ICU patients. The CRRT parameters and the duration of therapy will be monitored, depending on initial biochemical and clinical values of the patient. Part of the study is the follow-up of patients with a 3-month delay.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
- reaching criteria of severe sepsis, ICU admission
- pregnant women, younger than 18 years, reaching contraindications for initiation of renal replacement therapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mortality 28 days yes/no
- Secondary Outcome Measures
Name Time Method duration of mechanical ventilation 28 days days of mechanical ventilation including weening